ETF · ARK
ARCG Ark Genomic Revolution Ucits ETF AccumUSD
ISIN IE000O5M6XO1London Stock Exchange: ARCGARK Investment Management LP
- Healthcare
- ETF
- ISA
- SIPP
- Accumulating
Latest close
LSE£7.69
on
- Ongoing charge
- 0.79% a year
- Fund size
- £67.0m
Source: TradingView, as of , at least 15 min delayed
At a glance
As of 30/09/2026, ARCG (Ark Genomic Revolution Ucits ETF AccumUSD, ISIN IE000O5M6XO1) closed at £7.69 on the London Stock Exchange. Its ongoing charge is 0.79% a year (about £79 on £10,000). Over the year to 30/09/2026 its total return was +99.2%, or +93.0% after UK CPIH inflation.
Past returns
- 1 year to 30/09/2026
- +99.2%
- +93.0% after inflation (UK CPIH)
Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Calendar-year and 12-month returns
Calendar-year returns of Ark Genomic Revolution Ucits ETF AccumUSD in pounds (price, with income reinvested in the fund): 2025 +15.5%; 2026 to 30/09/2026 +83.8%. Returns of Ark Genomic Revolution Ucits ETF AccumUSD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +108.0%; to 30/09/2025: +2.5%.
| Year | Return | After inflation | Return shown as a bar |
|---|---|---|---|
| to | +83.8% | +78.7% | |
| +15.5% | +11.6% |
| 12 months to | Return | After inflation |
|---|---|---|
| from | +108.0% | Not available |
| from | +2.5% | −1.5% |
Source: Fundology, from recorded closes and the data vendor’s weekly price history, as of , inflation: ONS CPIH
How we work it out:Calendar-year returnsWhat a calendar-year return isAccumulating and distributing
Risk: volatility and largest fall
Volatility (annualised)
43.9%over 1 year
Annualised from weekly returns. Higher means bumpier.
- Largest fall since April 2024
- −37.0%
- From to
- Lowest 12-month return
- −24.2%
- 12 months to
- Highest 12-month return
- +102.2%
- 12 months to
- Below its highest weekly close since April 2024
- 0.0%
- High of , latest
In words: Volatility of Ark Genomic Revolution Ucits ETF AccumUSD in pounds, annualised from weekly returns to 30/09/2026: 43.9% over 1 year. Largest fall in the price of Ark Genomic Revolution Ucits ETF AccumUSD since April 2024, in pounds: −37.0% from 14/02/2025 to 04/04/2025. The lowest 12-month return of Ark Genomic Revolution Ucits ETF AccumUSD in pounds (price, with income reinvested in the fund) since April 2024 was −24.2% (12 months to 23/05/2025); the highest was +102.2% (12 months to 25/09/2026). On 30/09/2026 the price of Ark Genomic Revolution Ucits ETF AccumUSD was at its highest weekly close since April 2024, in pounds.
Source: Fundology, from recorded closes and the data vendor’s weekly price history, as of , price, with income reinvested in the fund
How we work it out:Risk figuresFallsVolatilityLargest fall
Charges compared with similar funds
- Ongoing charge
- 0.79%
- a year
- On £10,000
- £79
- a year, roughly
- Over five years
- £389
- of £10,000, before growth
- 17 charge less
- 0 the same
- 0 charge more
Ongoing charge of Ark Genomic Revolution Ucits ETF AccumUSD 0.79% a year, as of 01/10/2026: 0 of the 17 other healthcare funds charge more, 0 the same and 17 less (share classes counted once).
Source: Fund ongoing charges via TradingView, as of
A lower charge is not a promise of a higher return: what the fund holds matters more. Charges are the fund’s own published ongoing charges figure.
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
Ark Genomic Revolution Ucits ETF AccumUSD is an exchange-traded fund (ETF) from ARK, launched in 2024.
It tracks the No Underlying Index.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.79% a year — about £79 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Key facts
- Ticker
- ARCG
- ISIN
- IE000O5M6XO1
- Provider
- ARK
- Tracks
- No index — the manager chooses the holdings
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Accumulating
- Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
- Ongoing charge
- 0.79% a year · about £79 on £10,000
- Fund size
- £67.0m
- Launched
- Domicile
- Ireland
- Can be held in
- ISA and SIPP
- Currency hedged
- No
- Price currency
- Pounds (GBP)
- Category
- Healthcare
Price chart
Since 29/07/2026, the closing price went from £5.26 on 29/07/2026 to £7.69 on 30/09/2026 (+46.0%). The lowest close shown was £5.26 on 29/07/2026 and the highest £7.69 on 30/09/2026.
Chart: closing prices we have recorded since 29/07/2026.
Source: TradingView, as of , at least 15 min delayed
Five years of prices, and after inflation
9 weekly closes, from 29/07/2026 to 30/09/2026. The same history in September 2026 pounds, adjusted with ONS CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
Risk and return in depth
Sharpe, Sortino and Calmar ratios
Sharpe, Sortino and Calmar ratios over 1 year, from weekly returns in pounds.
With a free accountRolling returns
The full range of 76 rolling 12-month returns since April 2024, in pounds, with how often they were above zero.
With a free accountLargest falls and recoveries
The 3 largest falls since April 2024, in pounds, with how many weeks each took to reach its low and to recover.
With a free account
Create a free account to see the risk ratios, every rolling return and each large fall and its recovery
Sign-up takes an email address. There is no card to enter and nothing to pay.
Moves compared with a similar fund
Correlation and beta of weekly returns in pounds against iShares Core MSCI World UCITS ETF, over the three years to 30/09/2026 (121 weeks).
Pro
Pro — currently by invitation
Pro includes moves against a comparable fund
Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].
Questions people ask
What is the ongoing charge of ARCG?
The ongoing charge of ARCG is 0.79% a year — about £79 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Ark Genomic Revolution Ucits ETF AccumUSD 0.79% a year, as of 01/10/2026: 0 of the 17 other healthcare funds charge more, 0 the same and 17 less (share classes counted once).
Is ARCG accumulating or distributing?
ARCG is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
What is the ISIN of ARCG?
The ISIN of ARCG is IE000O5M6XO1. An ISIN identifies one exact share class of a fund; ARCG is its ticker on the London Stock Exchange.
What were ARCG’s returns in each of the last five years?
Calendar-year returns of ARCG in pounds (price, with income reinvested in the fund): 2025 +15.5%; 2026 to 30/09/2026 +83.8%. Past performance is not a guide to future returns.
How has ARCG done after inflation?
Over the year to 30/09/2026 ARCG’s total return was +99.2%, or +93.0% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £2.3bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £1.8bn
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £555m
- ESIHiShares MSCIEurope Health Care Sector UCITS ETF AccumEUR0.18% a year · £555m
- XSHCXtrackers MSCI USA Health Care UCITS ETF0.12% a year · £548m
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £547m
- AGESiShares Ageing Population UCITS ETF0.40% a year · £509m
- 0MP1iShares STOXX Europe 600 Health Care UCITS ETF (DE)0.46% a year · £453m
Sources and dates
- Prices
- London Stock Exchange closes via TradingView, at least 15 minutes delayed, latest
- Returns
- TradingView reported returns (net asset value with income reinvested where available)
- Calendar years, risk
- Fundology, from recorded closes (weekly history from the data vendor where our record is short)
- Inflation
- ONS CPIH, latest month used August 2026
- Charges
- The fund’s ongoing charges figure, via TradingView
- Identity
- FCA Financial Instruments Reference Data System (FIRDS) and the issuer
- Fund size
- TradingView, converted to pounds at the latest ECB reference rate
Methodology:Data sourcesReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.